Skip to main navigation Skip to search Skip to main content

Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer

  • Umang Swami
  • , Pedro Isaacsson Velho
  • , Roberto Nussenzveig
  • , Jonathan Chipman
  • , Victor Sacristan Santos
  • , Stephanie Erickson
  • , Divya Dharmaraj
  • , Ajjai Shivaram Alva
  • , Ulka N. Vaishampayan
  • , John Esther
  • , Andrew W. Hahn
  • , Benjamin Louis Maughan
  • , Emmanuel S. Antonarakis
  • , Neeraj Agarwal

Research output: Contribution to journalArticlepeer-review

Abstract

Presence of tumor mutation in speckle-type pox virus and zinc finger protein (SPOP) gene was associated with improved survival outcomes in men with de novo metastatic castration-sensitive prostate cancer receiving standard androgen deprivation therapy.

Original languageEnglish (US)
Pages (from-to)652-656
Number of pages5
JournalEuropean Urology
Volume78
Issue number5
DOIs
StatePublished - Nov 2020

Keywords

  • Androgen deprivation therapy
  • Metastatic hormone-sensitive prostate cancer
  • Overall survival
  • Progression-free survival
  • SPOP

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer'. Together they form a unique fingerprint.

Cite this